Status:
UNKNOWN
Key Specialized Monitoring of Clinical Safety of Pudilan Xiaoyan Oral Liquid in the Real World
Lead Sponsor:
China Academy of Chinese Medical Sciences
Collaborating Sponsors:
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Conditions:
Respiratory Infectious Diseases
Eligibility:
All Genders
18-80 years
Brief Summary
To obtain the characteristics of adverse reactions/incidents, analyze the influencing factors and calculate the incidence of adverse reactions/incidents monitored by Pudilan Xiaoyan Oral Liquid in key...
Eligibility Criteria
Inclusion
- (1)Upper respiratory tract infection patients using Pudilan antiphlogistic oral liquid ;
- (2)Aged between 18 and 80.
Exclusion
- Lactating women, pregnant women, pregnant planners, psychiatric patients, etc.
Key Trial Info
Start Date :
July 17 2019
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 31 2021
Estimated Enrollment :
10000 Patients enrolled
Trial Details
Trial ID
NCT04031651
Start Date
July 17 2019
End Date
December 31 2021
Last Update
July 24 2019
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.